OpenURL Connection Search

Select item for more details and to access through your institution.

Development and validation of a haematuria cancer risk score to identify patients at risk of harbouring cancer.
Published in:
2019
By:
- Tan, W. S.;
- Ahmad, A.;
- Feber, A.;
- Mostafid, H.;
- Cresswell, J.;
- Fankhauser, C. D.;
- Waisbrod, S.;
- Hermanns, T.;
- Sasieni, P.;
- Kelly, J. D.;
- Khetrapal, P;
- Baker, H;
- Sridhar, AN;
- Lamb, BW;
- Ocampo, F;
- McBain, H;
- Baillie, K;
- Middleton, K;
- Watson, D;
- Knight, H
Publication type:
journal article
Exploring patients' experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach.
Published in:
BJU International, 2020, v. 125, n. 5, p. 669, doi. 10.1111/bju.15008
By:
- Tan, Wei Shen;
- Teo, Chin Hai;
- Chan, Delcos;
- Ang, Kar Mun;
- Heinrich, Malgorzata;
- Feber, Andrew;
- Sarpong, Rachael;
- Williams, Norman;
- Brew‐Graves, Chris;
- Ng, Chirk Jenn;
- Kelly, John;
- Khetrapal, P.;
- Sridhar, A.;
- Baker, H.;
- Ocampo, F.;
- Whotton, N.;
- Dent, K.;
- Pearson, S.;
- Hatton, J.;
- Newton, M.
Publication type:
Article
Mixed‐methods approach to exploring patients' perspectives on the acceptability of a urinary biomarker test in replacing cystoscopy for bladder cancer surveillance.
Published in:
BJU International, 2019, v. 124, n. 3, p. 408, doi. 10.1111/bju.14690
By:
- Tan, Wei Shen;
- Teo, Chin Hai;
- Chan, Delcos;
- Heinrich, Malgorzata;
- Feber, Andrew;
- Sarpong, Rachael;
- Allan, Jennifer;
- Williams, Norman;
- Brew‐Graves, Chris;
- Ng, Chirk Jenn;
- Kelly, John D.;
- Khetrapal, P;
- ridhar, A;
- Baker, H;
- Ocampo, F;
- Whotton, N;
- Dent, K;
- Pearson, S;
- Hatton, J;
- Newton, M
Publication type:
Article

Found: 3

Development and validation of a haematuria cancer risk score to identify patients at risk of harbouring cancer.

Exploring patients' experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach.

Mixed‐methods approach to exploring patients' perspectives on the acceptability of a urinary biomarker test in replacing cystoscopy for bladder cancer surveillance.